FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to manufacturing of vaccines for intranasal introductions. There is offered composition to be delivered through mucous membrane, containing two or more following agents: a capsular oligosaccharide antigen which induces immune response on Haemophilus influenzae; and (b) a capsular oligosaccharide antigen which induces immune response on Neisseria meningitidis; with specified antigens conjugated with a carrier protein.
EFFECT: combination allows for single introduction to immunisation against two separate agents of the systemic disease, namely bacterial meningitis.
20 cl, 4 dwg
